Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Srinivas N. Tenjarla"'
Autor:
Terry G. Feldman, David DeMagistris, Michael Corbo, Thomas J. Franz, Vinod P. Shah, Gordon L. Flynn, Jonas C. T. Wang, David M. Pearce, Avaraham Yacobi, Joel A. Sequeira, Joel L. Zatz, James Swarbrick, Srinivas N. Tenjarla, Deborah R. Miran
Publikováno v:
Pharmaceutical Research. 16:1325-1330
The FDA recently issued a guidance covering practices of scaleup and post approval changes with semisolids (SUPAC-SS). This guidance outlines the steps that must be taken by a company to maintain certification of its semisolid dermatological products
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff143977548ba92d5eb9b1ea255b8de3
https://doi.org/10.1023/a:1018997520950
https://doi.org/10.1023/a:1018997520950
Autor:
John M. Holbrook, Joseph Entrekin, Wayne T. Harris, Srinivas N. Tenjarla, Cecelia Mead, Jeffrey Smith
Publikováno v:
Journal of Pharmaceutical Sciences. 84:640-642
The activity of n-pentyl N-acetylprolinate (PNAP) as a transdermal penetration enhancer was investigated. PNAP was synthesized from L-proline by acetylation with acetic anhydride, followed by acid-catalyzed esterification with 1-pentanol. Structure c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8414d3bbafd176eb17a7e58c29369bbb
https://doi.org/10.1002/jps.2600840522
https://doi.org/10.1002/jps.2600840522